ZTZoetis ZTS · NYSE
$79.71 +0.42% (+$0.33)
- Market cap
- $32.8B
- Enterprise value
- $40.6B
- P/E
- 12.5x
- Forward P/E
- 11.3x
- PEG
- 1.6x
- P/S
- 3.4x
- P/FCF
- 13.9x
- EV/EBITDA
- 10.5x
- ROIC
- 21.6%
- Bruto marža
- 70.9%
- Neto marža
- 27.5%
- Dividend yield
- 2.63%
- Payout ratio
- 33.0%
- Neto dolg/EBITDA
- 2.0x
- Beta
- 0.74
- Free float
- 99.8%
O podjetju
Zoetis Inc. (ZTS) is a global pharmaceutical company focused on animal health, headquartered in the USA. The company specializes in the development, manufacturing, and sale of medications and vaccines for animals. Zoetis provides a wide range of products for animal treatment and disease prevention in both domestic pets and livestock. Their portfolio includes medications for animals such as dogs, cats, cattle, pigs, poultry, and others. With its research, innovations, and global presence, Zoetis has gained a leading position in the field of animal health. The company focuses on improving the quality of life for animals and supports animal health worldwide. Zoetis Inc. (ZTS) shares can be an attractive investment opportunity for investors monitoring the animal health sector and valuing stability and long-term growth in this industry.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Kristin C. Peck
Employees
14,500
Headquarters
Parsippany
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke